620 related articles for article (PubMed ID: 18989537)
21. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
22. Clinical characteristics and outcome of inpatients versus outpatients with venous thromboembolism: findings from the RIETE Registry.
Maestre A; Sánchez R; Rosa V; Aujesky D; Lorenzo A; Barillari G; Monreal M;
Eur J Intern Med; 2010 Oct; 21(5):377-82. PubMed ID: 20816588
[TBL] [Abstract][Full Text] [Related]
23. Prognostic factors for recurrence of venous thromboembolism (VTE) or bleeding during long-term secondary prevention of VTE with ximelagatran.
Eriksson H; Lundström T; Wåhlander K; Clason SB; Schulman S;
Thromb Haemost; 2005 Sep; 94(3):522-7. PubMed ID: 16268466
[TBL] [Abstract][Full Text] [Related]
24. Venous thromboembolism in patients with renal insufficiency: findings from the RIETE Registry.
Monreal M; Falgá C; Valle R; Barba R; Bosco J; Beato JL; Maestre A;
Am J Med; 2006 Dec; 119(12):1073-9. PubMed ID: 17145252
[TBL] [Abstract][Full Text] [Related]
25. Treatment with dabigatran or warfarin in patients with venous thromboembolism and cancer.
Schulman S; Goldhaber SZ; Kearon C; Kakkar AK; Schellong S; Eriksson H; Hantel S; Feuring M; Kreuzer J
Thromb Haemost; 2015 Jul; 114(1):150-7. PubMed ID: 25739680
[TBL] [Abstract][Full Text] [Related]
26. The association between white blood cell count and acute myocardial infarction in-hospital mortality: findings from the National Registry of Myocardial Infarction.
Grzybowski M; Welch RD; Parsons L; Ndumele CE; Chen E; Zalenski R; Barron HV
Acad Emerg Med; 2004 Oct; 11(10):1049-60. PubMed ID: 15466147
[TBL] [Abstract][Full Text] [Related]
27. High factor VIII levels independently predict venous thromboembolism in cancer patients: the cancer and thrombosis study.
Vormittag R; Simanek R; Ay C; Dunkler D; Quehenberger P; Marosi C; Zielinski C; Pabinger I
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2176-81. PubMed ID: 19778945
[TBL] [Abstract][Full Text] [Related]
28. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.
Marchena PJ; Nieto JA; Guil M; García-Bragado F; Rabuñal R; Boccalon H; Trujillo-Santos J; Monreal M;
Thromb Haemost; 2012 Jan; 107(1):37-43. PubMed ID: 22116496
[TBL] [Abstract][Full Text] [Related]
29. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
[TBL] [Abstract][Full Text] [Related]
30. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.
Trujillo-Santos J; Gussoni G; Gadelha T; Sänchez Muñoz-Torrero JF; Barron M; Lopez L; Ruiz-Ruiz J; Fernandez-Capitan C; Lorente M; Monreal M;
Thromb Res; 2014 May; 133 Suppl 2():S29-34. PubMed ID: 24862142
[TBL] [Abstract][Full Text] [Related]
31. Gender differences in cancer patients with acute venous thromboembolism.
Martín-Martos F; Trujillo-Santos J; Barrón M; Vela J; Javier Marchena P; Braester A; Hij A; Hernández-Blasco L; Verhamme P; Manuel M;
Thromb Res; 2015 Feb; 135 Suppl 1():S12-5. PubMed ID: 25903526
[TBL] [Abstract][Full Text] [Related]
32. Suboptimal doses of low molecular weight heparin and acute venous thromboembolism. Data from the RIETE registry.
Bruscas MJ; Nieto JA; Perez-Pinar M; López-Jiménez L; Fernández-Capitán C; López-Chuliá F; Orue-Lecue MT;
Ann Hematol; 2007 Jul; 86(7):519-26. PubMed ID: 17437112
[TBL] [Abstract][Full Text] [Related]
33. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
34. Periprocedural anticoagulation management of patients with venous thromboembolism.
McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
[TBL] [Abstract][Full Text] [Related]
35. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
36. Association between circulating white blood cell count and cancer mortality: a population-based cohort study.
Shankar A; Wang JJ; Rochtchina E; Yu MC; Kefford R; Mitchell P
Arch Intern Med; 2006 Jan; 166(2):188-94. PubMed ID: 16432087
[TBL] [Abstract][Full Text] [Related]
37. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
[TBL] [Abstract][Full Text] [Related]
38. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
[TBL] [Abstract][Full Text] [Related]
39. Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry.
Imberti D; Agnelli G; Ageno W; Moia M; Palareti G; Pistelli R; Rossi R; Verso M;
Haematologica; 2008 Feb; 93(2):273-8. PubMed ID: 18223291
[TBL] [Abstract][Full Text] [Related]
40. Rates of venous thromboembolism occurrence in medical patients among the insured population.
Spyropoulos AC; Hussein M; Lin J; Battleman D
Thromb Haemost; 2009 Nov; 102(5):951-7. PubMed ID: 19888534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
